DAYNA GIORDANO: Open Payments
NPI 1811437973 · NEW HAVEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$17,042 in 247 payments from 21 companies in 2025. Trend: 2023 $9,063 · 2024 $27,325 · 2025 $17,042
Honoraria: $6,500Food & beverage: $5,855Speaker / faculty: $3,750Travel & lodging: $937
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 40 | $8,635 |
| ABBVIE INC. | 43 | $4,674 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 38 | $1,043 |
| Vanda Pharmaceuticals Inc. | 30 | $601 |
| Alkermes, Inc. | 19 | $463 |
| Otsuka America Pharmaceutical, Inc. | 19 | $371 |
| Corium, LLC | 12 | $220 |
| E.R. Squibb & Sons, L.L.C. | 7 | $147 |
| Indivior Inc. | 5 | $144 |
| Neurocrine BioSciences, Inc. | 5 | $122 |
Products named: Auvelity, VRAYLAR, CAPLYTA, FANAPT, REXULTI, Symbravo, Azstarys, ARISTADA.
Industry payments across CT — which companies pay providers there.
